Characteristics of women who use hormonal contraceptives and their population-level impacts on HIV infection in a cohort of South African women (2002–2016)

References

• Joint United Nations Programme on HIV/AIDS (UNAIDS). UNAIDS Data 2017; [2017; cited 2019 Dec 12]. Available from: http://www.unaids.org/sites/default/files/media_asset/20170720_Data_book_2017_en.pdf.
   Google Scholar
• Harrison A, Colvin CJ, Kuo C, et al. Sustained high HIV incidence in young women in southern Africa: social, behavioral, and structural factors and emerging intervention approaches. Curr HIV/AIDS Rep. 2015;12(2):207–215.
   PubMed Web of Science ®Google Scholar
• Tanser F, Bärnighausen T, Dobra A, et al. Identifying ‘corridors of HIV transmission’ in a severely affected rural South African population: a case for a shift toward targeted prevention strategies. Int J Epidemiol. 2018;47(2):537–549.
   PubMed Web of Science ®Google Scholar
• Padian NS, van der Straten A, Ramjee G, et al. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomized controlled trial. Lancet. 2007;370(9583):251–261.
   PubMed Web of Science ®Google Scholar
• Skoler-Karpoff S, Ramjee G, Ahmed K, et al. Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomized, double-blind, placebo-controlled trial. Lancet. 2008;372(9654):1977–1987.
   PubMed Web of Science ®Google Scholar
• McCormack S, Ramjee G, Kamali A, et al. PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial. Lancet. 2010;376(9749):1329–1337.
   PubMed Web of Science ®Google Scholar
• Van Damme L, Corneli A, Ahmed K, et al. Preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2012;367(5):411–422.
   PubMed Web of Science ®Google Scholar
• Marrazzo JM, Ramjee G, Richardson BA, et al. Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2015;372(6):509–518.
   PubMed Web of Science ®Google Scholar
• Baeten JM, Palanee-Phillips T, Brown ER, et al. Use of a vaginal ring containing dapivirine for HIV-1 prevention in women. N Engl J Med. 2016;375(22):2121–2132.
   PubMed Web of Science ®Google Scholar
• Naidoo S, Wand H, Abbai NS, et al. High prevalence and incidence of sexually transmitted infections among women living in Kwazulu-Natal, South Africa. AIDS Res Ther. 2014;11(1):31.
   PubMedGoogle Scholar
• Balkus JE, Brown E, Palanee T, et al. An empiric HIV risk scoring tool to predict HIV-1 acquisition in African women. J Acquir Immune Defic Syndr. 2016;72:333–343.
   PubMed Web of Science ®Google Scholar
• Zuma K, Shisana O, Rehle TM, et al. New insights into HIV epidemic in South Africa: key findings from the national HIV prevalence, incidence and behaviour survey, 2012. Afr J AIDS Res. 2016;15(1):67–75.
   PubMed Web of Science ®Google Scholar
• Tanser F, Barnighausen T, Cooke GS, et al. Localized spatial clustering of HIV infections in a widely disseminated rural South African epidemic. Int J Epidemiol . 2009;38(4):1008–1016.
   PubMed Web of Science ®Google Scholar
• Tanser F, Oliveira T, Maheu-Giroux M, et al. Concentrated HIV sub-epidemics in generalized epidemic settings. Curr Opin HIV/AIDS. 2014;9(2):115–125.
   PubMed Web of Science ®Google Scholar
• Street R, Reddy T, Ramjee G. The generational effect on age disparate partnerships and the risk for human immunodeficiency virus and sexually transmitted infections acquisition. Int J STD Aids. 2016;27(9):746–752.
   PubMed Web of Science ®Google Scholar
• Wand H, Reddy T, Naidoo S, et al. A simple risk prediction algorithm for HIV transmission: results from HIV prevention trials in KwaZulu Natal, South Africa (2002–2012). AIDS Behav. 2018;22(1):325–336.
   PubMed Web of Science ®Google Scholar
• Wand H, Ramjee G. The effects of injectable hormonal contraceptives on HIV seroconversion and on sexually transmitted infections. AIDS. 2012;26:375–380.
   PubMed Web of Science ®Google Scholar
• Heffron R, Donnell D, Rees H, et al. Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis. 2012;12(1):19–26.
   PubMed Web of Science ®Google Scholar
• Hapgood JP, Kaushic C, Hel Z, et al. Hormonal contraception and HIV-1 acquisition: biological mechanisms. Endocr Rev. 2018;39(1):36–78.
   PubMed Web of Science ®Google Scholar
• Polis CB, Curtis KM, Hannaford PC, et al. An updated systematic review of epidemiological evidence on hormonal contraceptive methods and HIV acquisition in women. AIDS. 2016;30(17):2665–2683.
   PubMed Web of Science ®Google Scholar
• Polis CB, Westreich D, Balkus JE, et al. Assessing the effect of hormonal contraception on HIV acquisition in observational data: challenges and recommended analytic approaches. AIDS. 2013;27(1):S35–S43.
   PubMedGoogle Scholar
• Polis CB, Curtis KM. Use of hormonal contraceptives and HIV acquisition in women: a systematic review of the epidemiological evidence. Lancet Infect Dis. 2013;13(9):797–808.
   PubMed Web of Science ®Google Scholar
• Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomized, multicentre, open-label trial. Lancet. 2019;394:303–313. 10.1016/S0140-6736(19)31288-7.
   PubMed Web of Science ®Google Scholar
• Contraceptive eligibility for women at high risk of HIV. Guidance statement: recommendations on contraceptive methods used by women at high risk of HIV. Geneva: World Health Organization (WHO); 2019. Licence: CC BYNC-SA 3.0 IGO. [cited 2019 Nov 26]. https://www.who.int/reproductivehealth/contraceptive-eligibility-women-at-high-risk-of-HIV/en/
   Google Scholar
• Wand H, Ramjee G. Combined impact of sexual risk behaviors for HIV seroconversion among women in Durban, South Africa: implications for prevention policy and planning. AIDS Behav. 2011; 15(2):479–486.
   PubMed Web of Science ®Google Scholar
• Department of Health (South Africa) National Antenatal Sentinel HIV & Syphilis Prevalence Survey in South Africa 2008. Pretoria, South Africa: Department of Health (South Africa); 2009. [cited 2020 Mar 11].
   Google Scholar
• Ataguba JE, Akazili J, McIntyre D. Socioeconomic-related health inequality in South Africa: evidence from General Household Surveys. Int J Equity Health. 2011;10(1):48.
   PubMed Web of Science ®Google Scholar
• Shisana T, Rehle LC, Simbayi K, et al. South African national HIV prevalence, incidence and behaviour survey. Cape Town: HSRC Press; 2014. https://www.sciencedirect.com/science/article/pii/S235282731830017X#bbib47. Accessed 16 January 2020.
   Google Scholar
• Shisana O, Simbayi L. Nelson Mandela/HSRC Study of HIV/AIDS: South African National HIV prevalence, behavioral risks and mass media, household survey. Cape Town (South Africa): Human Sciences Research Council; 2002.
   Google Scholar
• Hunter M. The changing political economy of sex in South Africa: the significance of unemployment and inequalities to the scale of the AIDS pandemic. Soc Sci Med. 2007;64(3):689–700.
   PubMed Web of Science ®Google Scholar
• Parkhurst JO. Understanding the correlations between wealth, poverty and human immunodeficiency virus infection in African countries. Bull World Health Organ. 2010;88(7):519–526.
   PubMed Web of Science ®Google Scholar
• Stoebenau K, Heise L, Wamoyi J, et al. Revisiting the understanding of “transactional sex” in sub-Saharan Africa: a review and synthesis of the literature. Soc Sci Med. 2016; 168:186–197.
   PubMed Web of Science ®Google Scholar
• Wamoyi J, Stobeanau K, Bobrova N, et al. Transactional sex and risk for HIV infection in sub-Saharan Africa: a systematic review and meta-analysis. J Int AIDS Soc. 2016;19(1):20992
   PubMedGoogle Scholar
• Dunkle KL, Jewkes RK, Brown HC, et al. Transactional sex among women in Soweto, South Africa: prevalence, risk factors and association with HIV infection. Soc Sci Med. 2004;59(8):1581–1592.
   PubMed Web of Science ®Google Scholar
• Maharaj P, Cleland J. Condom use within marital and cohabiting partnerships in KwaZulu-Natal, South Africa. Stud Fam Plann. 2004;35(2):116–124.
   PubMed Web of Science ®Google Scholar
• Maharaj P. Patterns of condom use: perspectives of men in KwaZulu-Natal, South Africa. Dev South Afr. 2005;22(2):187–197.
   Google Scholar
• Luke N. Age and economic asymmetries in the sexual relationships of adolescent girls in sub-Saharan Africa. Stud Fam Plann. 2003;34(2):67–86. 40.
   PubMed Web of Science ®Google Scholar
• Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329(5996):1168–1174.
   PubMed Web of Science ®Google Scholar
• Bongaarts J, Casterline J. Fertility transition: is sub-saharan Africa different? Popul Dev Rev. 2013;38(Suppl. 1):153–168.
   PubMedGoogle Scholar
• Richardson ET, Collins SE, Kung T, et al. Gender inequality and HIV transmission: a global analysis. J Int AIDS Soc. 2014;17:19035.
   PubMed Web of Science ®Google Scholar